Position in DXCM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,697,876,797
+$126,560,447 QoQ
Shares Held
25,209,752
+0.8% QoQ
Ownership
6.68%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#2
of 951 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026VANGUARD CAPITAL MANAGEMENT LLC holds $42,273,882,945 across 116 Medical Devices names. DXCM ranks #7 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
113,750,994 | $10,321,765,195 | |
| 2 | SYK |
Stryker Corp
|
22,536,843 | $7,095,499,650 | |
| 3 | MDT |
Medtronic plc
|
83,816,735 | $6,556,983,179 | |
| 4 | BSX |
Boston Scientific Corp
|
97,087,553 | $4,143,696,762 | |
| 5 | EW |
Edwards Lifesciences Corp
|
37,615,952 | $3,402,739,017 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
29,724,359 | $1,902,656,219 | |
| 7 | DXCM |
Dexcom Inc
This page
|
25,209,752 | $1,697,876,797 | |
| 8 | STE |
STERIS plc
|
6,406,906 | $1,349,102,196 |
All Filings in DXCM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,697,876,797 | 25,209,752 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,571,316,350 | 25,020,961 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $1,811,668,090 | 28,848,218 | Shares | Sole | 2026-04-29 | |
| No filing history on record for this holder in this stock. | ||||||